Summary
This 2022 Lancet review by Crosbie and colleagues provides a comprehensive synthesis of evidence on endometrial cancer as a major and increasingly prevalent malignancy. The review addresses epidemiological patterns, established and emerging aetiological factors including obesity and metabolic dysfunction, pathophysiological mechanisms, diagnostic strategies, and contemporary therapeutic approaches. As a major clinical review, it appears designed to inform evidence-based clinical practice and prevention policy.
UK applicability
This review is directly applicable to UK clinical practice and policy, as endometrial cancer incidence and risk factor prevalence (particularly obesity-related) are significant public health concerns in the United Kingdom. The findings may inform NHS screening, prevention, and treatment protocols.
Key measures
Epidemiological trends in endometrial cancer incidence; risk factor associations (obesity, metabolic syndrome, hormonal factors); diagnostic modalities; treatment outcomes and management approaches
Outcomes reported
The review synthesises current evidence on endometrial cancer epidemiology, risk factors, pathophysiology, diagnostic approaches, and treatment modalities. It addresses systemic drivers of endometrial carcinogenesis including obesity and metabolic dysfunction alongside contemporary clinical practice.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.